Prognosis Prediction of Diffuse Large B-Cell Lymphoma in 18F-FDG PET Images Based on Multi-Deep-Learning Models

被引:4
|
作者
Qian, Chunjun [1 ,2 ,3 ,4 ]
Jiang, Chong [5 ]
Xie, Kai [2 ,3 ,4 ]
Ding, Chongyang [6 ]
Teng, Yue [5 ]
Sun, Jiawei [2 ,3 ,4 ]
Gao, Liugang [2 ,3 ,4 ]
Zhou, Zhengyang [5 ]
Ni, Xinye [2 ,3 ,4 ]
机构
[1] Changzhou Inst Technol, Hertfordshire Coll, Changzhou 213032, Peoples R China
[2] Nanjing Med Univ, Changzhou Peoples Hosp 2, Changhzou 213004, Peoples R China
[3] Jiangsu Prov Engn Res Ctr Med Phys, Changzhou 213003, Peoples R China
[4] Nanjing Med Univ, Ctr Med Phys, Changzhou 213003, Peoples R China
[5] Nanjing Univ, Nanjing Drum Tower Hosp, Affiliated Hosp, Med Sch,Dept Nucl Med, Nanjing 210008, Peoples R China
[6] Nanjing Med Univ, Affiliated Hosp 1, Jiangsu Prov Hosp, Dept Nucl Med, Nanjing 210029, Peoples R China
基金
中国国家自然科学基金;
关键词
Feature extraction; Prognostics and health management; Predictive models; Deep learning; Lesions; Radiomics; Biomedical imaging; Prognosis prediction; deep learning; diffuse large B-cell lymphoma; PET image; multi-R-signature; RISK STRATIFICATION; FDG-PET; RADIOMICS; LINE; IPI;
D O I
10.1109/JBHI.2024.3390804
中图分类号
TP [自动化技术、计算机技术];
学科分类号
0812 ;
摘要
Diffuse large B-cell lymphoma (DLBCL), a cancer of B cells, has been one of the most challenging and complicated diseases because of its considerable variation in clinical behavior, response to therapy, and prognosis. Radiomic features from medical images, such as PET images, have become one of the most valuable features for disease classification or prognosis prediction using learning-based methods. In this paper, a new flexible ensemble deep learning model is proposed for the prognosis prediction of the DLBCL in 18 F-FDG PET images. This study proposes the multi-R-signature construction through selected pre-trained deep learning models for predicting progression-free survival (PFS) and overall survival (OS). The proposed method is trained and validated on two datasets from different imaging centers. Through analyzing and comparing the results, the prediction models, including Age, Ann abor stage, Bulky disease, SUVmax, TMTV, and multi-R-signature, achieve the almost best PFS prediction performance (C-index: 0.770, 95% CI: 0.705-0.834, with feature adding fusion method and C-index: 0.764, 95% CI: 0.695-0.832, with feature concatenate fusion method) and OS prediction (C-index: 0.770 (0.692-0.848) and 0.771 (0.694-0.849)) on the validation dataset. The developed multiparametric model could achieve accurate survival risk stratification of DLBCL patients. The outcomes of this study will be helpful for the early identification of high-risk DLBCL patients with refractory relapses and for guiding individualized treatment strategies.
引用
收藏
页码:4010 / 4023
页数:14
相关论文
共 50 条
  • [41] Prognostic Value of Baseline Radiomic Features of 18F-FDG PET in Patients with Diffuse Large B-Cell Lymphoma
    Lue, Kun-Han
    Wu, Yi-Feng
    Lin, Hsin-Hon
    Hsieh, Tsung-Cheng
    Liu, Shu-Hsin
    Chan, Sheng-Chieh
    Chen, Yu-Hung
    DIAGNOSTICS, 2021, 11 (01)
  • [42] The Impact of Segmentation Method and Target Lesion Selection on Radiomic Analysis of 18F-FDG PET Images in Diffuse Large B-Cell Lymphoma
    Botta, Francesca
    Ferrari, Mahila
    Raimondi, Sara
    Corso, Federica
    Lo Presti, Giuliana
    Mazzara, Saveria
    Farulla, Lighea Simona Airo
    Radice, Tommaso
    Vanazzi, Anna
    Derenzini, Enrico
    Travaini, Laura Lavinia
    Ceci, Francesco
    APPLIED SCIENCES-BASEL, 2022, 12 (19):
  • [43] 18F-Choline and 18F-FDG PET/CT in a Patient With Diffuse Large B-Cell Lymphoma and Recurrent Prostate Cancer
    De Leiris, Nicolas
    Riou, Laurent
    Leenhardt, Julien
    Vuillez, Jean-Philippe
    Djaileb, Loic
    CLINICAL NUCLEAR MEDICINE, 2018, 43 (12) : E471 - E472
  • [44] Unanticipated Biatrial 18F-Fluorodeoxyglucose (18F-FDG) Uptake in Diffuse Large B-cell Lymphoma Surveillance PET/CT
    Suthar, Pokhraj P.
    Virmani, Sumeet
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (08)
  • [45] Combined Visual and Semiquantitative Evaluation Improves Outcome Prediction by Early Midtreatment 18F-FDG PET in Diffuse Large B-Cell Lymphoma
    Gyorke, Tamas
    Carr, Robert
    Cerci, Juliano J.
    Meneghetti, Claudio
    Redondo, Francisca
    Celli, Monica
    Gorospe, Charity
    Auewarakul, Chirayu U.
    Jorgov, Linda
    Paez, Diana
    Fanti, Stefano
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61 (07) : 999 - 1005
  • [46] 18f-FDG PET/CT Baseline Rdiomics Features Improve the Prediction of Treatment Outcome in Diffuse Large B-Cell Lymphoma Patients
    Eertink, Jakoba J.
    van de Brug, Tim
    Wiegers, Sanne E.
    Zwezerijnen, Gerben J. C.
    Pfaehler, Elisabeth
    Lugtenburg, Pieternella J.
    van der Holt, Bronno
    de Vet, Henrica C. W.
    Hoekstra, Otto S.
    Boellaard, Ronald
    Zijlstra, Josee M.
    BLOOD, 2020, 136
  • [47] Detection of intravascular large B-cell lymphoma using 18F-FDG PET/CT
    Fan, Min
    Southwest, Chunyin Zhang
    Liu, Yong
    Zhao, Jie
    ASIAN JOURNAL OF SURGERY, 2025, 48 (02) : 1335 - 1336
  • [48] Prognosis and imaging-time of chemotherapy on 18F-FDG PET/CT and MYC gene rearrangement in patients with diffuse large B-cell lymphoma
    Yuan, Ling
    Wu, Zhifang
    Liu, Jianzhong
    Li, Sijin
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [49] Evaluating ΔMTV%, ΔDmax%, and %ΔSUVmax of 18F-FDG PET/CT for mid-treatment efficacy and prognosis in diffuse large B-cell lymphoma
    Cui, Yali
    Li, Yao
    Hu, Wenhao
    Wu, Zhifang
    Li, Sijin
    Wang, Hongliang
    DISCOVER ONCOLOGY, 2025, 16 (01)
  • [50] High Metabolic Heterogeneity on Baseline 18F-FDG PET/CT Predicts Worse Prognosis of Newly Diagnosed Diffuse Large B-Cell Lymphoma
    Senjo, Hajime
    Hirata, Kenji
    Izumiyama, Koh
    Minauchi, Koichiro
    Itoh, Kazuo
    Tsukamoto, Eriko
    Mori, Akio
    Ota, Shuichi
    Hashimoto, Daigo
    Teshima, Takanori
    BLOOD, 2019, 134